Sakar Healthcare Limited has informed the Exchange regarding a press release dated November 11, 2025, titled "Press Release - Consolidated and Standalone Unaudited Financial Results for the quarter and half year ended September 30, 2025".
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sakar Healthcare Limited has submitted a press release dated November 11, 2025, to the NSE containing its consolidated and standalone unaudited financial results for the quarter ended September 30, 2025 (Q2 FY26) and the half year ended on the same date (H1 FY26). The filing itself is a routine regulatory disclosure sharing the press release document with the exchange. The detailed revenue, profit, and expense figures are contained within the press release rather than in this announcement text. Q2 ending September typically covers the post-monsoon period and is often relevant for healthcare companies due to seasonal illness trends.
This is a standard compliance filing accompanying the company's quarterly results announcement; it does not by itself signal a positive or negative event. Shareholders should review the actual numbers in the press release for any changes in revenue, margins, or profit compared to the previous quarter and year-ago period.